vimarsana.com
Home
Live Updates
FMT in a Pill: FDA OKs Second Product to Prevent Recurrent C
FMT in a Pill: FDA OKs Second Product to Prevent Recurrent C
FMT in a Pill: FDA OKs Second Product to Prevent Recurrent C difficile
Clinicians now have two approved options for recurrent infections after antibiotic treatment.
Related Keywords
Boston ,
Massachusetts ,
United States ,
Jessica Allegretti ,
Joseph Thome ,
Drug Administration On ,
Reuters ,
Colitis Center At Brigham Women Hospital ,
Massachusetts Based Seres Therapeutics ,
Drug Administration ,
Colitis Center ,
C Diff Infection ,
Clostridium Difficile Infection ,
Lostridium Difficile Associated Disease ,
C Diff Associated Disease ,
Bacteria ,
Microbiome ,
Large Intestinal ,
Fecal Transplantation ,
Stool Transplant ,
Ecal Bacteriotherapy ,
Fecal Microbiota Transplantation ,
Mt ,
Antibiotics ,
Igecycline ,
Biologic Therapy ,
Us Food And Drug Administration ,
Nited States Food And Drug Administration ,
Fda ,
Diarrhea ,
Abdomi ,